116 related articles for article (PubMed ID: 38836854)
21. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
22. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
23. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
24. Cancer incidence in the U.S. military population: comparison with rates from the SEER program.
Zhu K; Devesa SS; Wu H; Zahm SH; Jatoi I; Anderson WF; Peoples GE; Maxwell LG; Granger E; Potter JF; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1740-5. PubMed ID: 19505907
[TBL] [Abstract][Full Text] [Related]
25. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
[TBL] [Abstract][Full Text] [Related]
26. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
Feuer EJ; Merrill RM; Hankey BF
J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965
[TBL] [Abstract][Full Text] [Related]
27. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
[TBL] [Abstract][Full Text] [Related]
28. Comorbidity and stage at diagnosis among lung cancer patients in the US military health system.
Lin J; McGlynn KA; Nations JA; Shriver CD; Zhu K
Cancer Causes Control; 2020 Mar; 31(3):255-261. PubMed ID: 31984449
[TBL] [Abstract][Full Text] [Related]
29. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.
Cetin K; Beebe-Dimmer JL; Fryzek JP; Markus R; Carducci MA
Urology; 2010 Jun; 75(6):1396-404. PubMed ID: 19969335
[TBL] [Abstract][Full Text] [Related]
30. Breast carcinoma survival analysis for African American and white women in an equal-access health care system.
Wojcik BE; Spinks MK; Optenberg SA
Cancer; 1998 Apr; 82(7):1310-8. PubMed ID: 9529023
[TBL] [Abstract][Full Text] [Related]
31. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
32. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
33. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
34. Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries.
Enewold L; Zhou J; McGlynn KA; Devesa SS; Shriver CD; Potter JF; Zahm SH; Zhu K
Cancer; 2012 Mar; 118(5):1397-403. PubMed ID: 21837685
[TBL] [Abstract][Full Text] [Related]
35. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.
Herget KA; Patel DP; Hanson HA; Sweeney C; Lowrance WT
Cancer Med; 2016 Jan; 5(1):136-41. PubMed ID: 26628287
[TBL] [Abstract][Full Text] [Related]
36. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
37. The Relative Importance of Race Compared to Health Care and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach.
Hanson HA; Martin C; O'Neil B; Leiser CL; Mayer EN; Smith KR; Lowrance WT
J Urol; 2019 Dec; 202(6):1209-1216. PubMed ID: 31246547
[TBL] [Abstract][Full Text] [Related]
38. Black-white differences in tumor grade (aggressiveness) at diagnosis of prostate cancer, 1992-1998.
Polednak AP
Ethn Dis; 2002; 12(4):536-40. PubMed ID: 12477140
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
